APIM THERAPEUTICS
APIM Therapeutics is based on an original discovery by Prof. Marit Otterlei and co-inventors at the Department of Cancer Research and Molecular Medicine at NTNU (Trondheim, Norway). The company is currently developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen), a key DNA repair protein regulating cellular responses to DNA damage and stress.
APIM THERAPEUTICS
Industry:
Biotechnology Finance Therapeutics Venture Capital
Founded:
2009-01-01
Address:
Trondheim, Sor-Trondelag, Norway
Country:
Norway
Website Url:
http://www.apimtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+47 73 49 4002
Email Addresses:
[email protected]
Total Funding:
3.01 M USD
Technology used in webpage:
SPF Japanese Yen SingleHop
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Employees Featured
Founder
Investors List
Investinor
Investinor investment in Venture Round - APIM Therapeutics
TeleVenture Management
TeleVenture Management investment in Venture Round - APIM Therapeutics
Sarsia Seed Management
Sarsia Seed Management investment in Venture Round - APIM Therapeutics
Birk Venture
Birk Venture investment in Venture Round - APIM Therapeutics
Sarsia Seed Management
Sarsia Seed Management investment in Venture Round - APIM Therapeutics
Birk Venture
Birk Venture investment in Venture Round - APIM Therapeutics
Official Site Inspections
http://www.apimtherapeutics.com Semrush global rank: 5.84 M Semrush visits lastest month: 1.42 K
- Host name: am5.fcomet.com
- IP address: 194.233.175.97
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
